RAC is valued at laughable $6.3 million which is a PURE GIFT for a company with a Cancer Drug in Phase 3 which has around $500 million in annual sales potential .A Partnerdeal for the Drug could bring in more than $20 million in upfront payments alone . The problem here is that this stock is still undiscovered .
Bitron (BIT) as an example is valued at $80 million and their most advanced drug is still in early Phase 2 trial means they are still minimum 5-7 years away from potential market approval IF drug doesnt fail in phase 3 trial . RAC is the wayyy better investment with massive upside potential this stockjust need more PR and then it will skyrocketing .GLTA
RAC is valued at laughable $6.3 million which is a PURE GIFT for...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |
